Gariti, P <br/><br/>
Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting.  [electronic resource] 

 -  Drug and alcohol dependence  Apr 1999 
 - 111-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0376-8716 
<br/><br/><label>Standard No.: </label>10.1016/s0376-8716(98)00163-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Adult<br/>Biomarkers--blood<br/>Chi-Square Distribution<br/>Cholinergic Agents--administration & dosage<br/>Cotinine--blood<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Nicotine--administration & dosage<br/>Sex Factors<br/>Smoking Cessation--methods<br/>Substance Withdrawal Syndrome--prevention & control<br/>Tobacco Use Disorder--blood<br/>Treatment Outcome